Skip to main content
. 2009 Oct 23;37(22):7468–7482. doi: 10.1093/nar/gkp757

Figure 3.

Figure 3.

Uptake of fluorescently labeled ssODNs. (A) Immunofluorescence analysis of myoblasts treated with control or targeting ssODNs 2 h after removal of the transfection reagent. Bright fluorescence could be detected virtually all cells transfected with ssODNs. (B) FACS dot-plots of CY3-positive cells 1 day after ssODN transfection. (C) No significant differences were detected in the number of CY3-positive cells transfected with different ssODNs and analyzed for up to 7 days after transfection.

HHS Vulnerability Disclosure